NEW YORK (GenomeWeb News) – Mediomics has reeled in a $997,251 grant from the National Cancer Institute to continue developing technologies for monitoring the titer and quality of recombinant biologics, the company said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.
An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.
Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions.
Ancestry.com is eyeing an expansion into genomic risk assessments, the Verge reports.